The dips are perfectly explained and as much as I am
The dips are perfectly explained and as much as I am frustrated at least we can make sense of it. Cellceutix just tapped spire for 1.1 million shares average purchase price of 1.55... They are not an invest and hold company, they are a loan company. They unload thier shares down through 1.55 , and then the shorts and manipulators who know we are in oversold territory take it down a little further using the MMs and computer manipulation. Shake out the weeks hands and ride for the trip back up to an easy 1.80 when Aspire is done.
It sucks real bad my bigger heart ache is that Judge letting Rosen do what they do and cause a lot of suffering for small companies. She should have s case already and sent Rosen a packing notice, an issued a right to sue so Cellceutix could go after Rosen, Zagami and their cohorts!
I do agree with you that we are all allowed to get edgy... it is our money on the line not someone else's.
GLTM
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
If you try to defend yourself against lies of the board moderators your post will be deleted. Just like the board they claim to be better than!!! Watch who you trust especially the "long term investors" that support the real attackers!
Scroll down for more posts ▼
Top 10 Most Recent News Articles
You'll know it's a topsy-turvy market when hefty firms start switching their stock exchange allegiance. This year, nine noteworthy companies, with a collective market heft of nearly half a trillion dollars, kissed Nasdaq goodbye and nestled into the New York Stock Exchange (NYSE). Now, why would these big shots make the shift, you ask? Let's dive into the nitty-gritty....
Continue Reading
A Historic Melting Pot in Modern Times You land on Hainan, and it's not just about palm trees and endless beaches anymore. The place is serving up a wild blend of cultural cocktail through fascinating architecture that screams, 'We’ve been doing this global thing before it was cool.' Anna Bondarenko from Russia found herself puzzled walking through Qilou Old Street....
Continue Reading
Whistleblower Complaint Rocks Madrigal Let me tell you, today's chatter isn't for the faint-hearted investor. Madrigal Pharmaceuticals (NASDAQ: MDGL) is under scrutiny, and it's making waves. The gears started turning when their former Senior VP and Head of Clinical Development unloaded a bombshell: he reported dirt on Madrigal's safety and efficacy data for Rezdiffra,...
Continue Reading
The Road to Green: LiuGong’s Ambitious Vision In a world where more heads are turning towards sustainability, LiuGong stepped up and showcased its green aspirations with flare at the 2026 Global Dealer Conference held from November 10 to 12 in Liuzhou, China. Over 2,000 attendees, ranging from dealers to customers, were in attendance to witness what seemed to be both a...
Continue Reading
A Gathering Storm for D-Wave: Seeking Accountability The air's thick with tension in investor circles these days, especially if you're holding shares of D-Wave Quantum Inc. (NASDAQ: QBTS). If you've suffered losses between February 26 and August 25, 2026, you might want to take note: The deadline to move for lead plaintiff status in a class action against D-Wave is fast...
Continue Reading
Nuix Shakes Things Up with New Leadership Nuix, a notable player in the investigative analytics and intelligence software space, just leveled up its game by bringing in Lori Cornmesser as the Global Vice President, Partner Ecosystems. This ain't your average hire. Cornmesser's been around the block—over 25 years, in fact—building and leading partner ecosystems...
Continue Reading
Minhang's Unique Blend of Action and Relaxation Tennis fans and journalists aren't exactly flocking to Minhang for a typical sports event feel. During the 2026 Rolex Shanghai Masters, something magical happened—intense tennis matches inside the court and a serene culinary oasis outside. You'd think these two worlds wouldn't mix, but Minhang pulled it off spectacularly....
Continue Reading
The Dawn of the Agent Web Well, here we are, standing at the cusp of a new digital frontier, folks. This ain't just another buzzword parade; this is the Open Agentic Web Challenge, courting developers with a $13K carrot to craft an interoperable playground for AI agents. Big names like Cognizant AI Lab, MIT Media Lab, and others are leading the charge. No small-time...
Continue Reading
Shining the Spotlight on Neurodivergent and Disabled Artists The curtains are about to rise for EPIC Players' 10th Anniversary Gala, and folks, it's more than just a party; it's a cause worth championing. Set for April 7, 2027, at New York's City Winery, this event is an invitation for brands to spotlight their support for Neurodivergent and Disabled artists. If you've...
Continue Reading
Ripping With A New Idea: A Simpler Tape Solution Every DIY-er and professional who's grappled with that pesky tape edge knows the struggle. The inventors in San Bernardino claim they've cracked the code with the QUICK FIND TAPE. It might not sound revolutionary at first blush, but picture this: no more squinting, squabbling, or ripping your nails apart to find where the...
Continue Reading
"
title="Health In Tech's Rocky Q3: Navigating Losses and Opportunities - Continue Reading"
aria-label="Continue reading: Health In Tech's Rocky Q3: Navigating Losses and Opportunities">
Continue Reading